Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Zevra Therapeutics Inc's Business Segments
Zevra Therapeutics Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
1
Largest Segment
Reportable
Total Revenue
$ 29
Regions Reported
-
Revenue Share by Reportable Segment - Q1 FY2026
- Reportable0%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Reportable | $ 36 | - |
Revenue by Product & Service Category - Q1 FY2026
- Miplyffa84.8%
- Olpruva1%
Revenue by Product & Service Category - Q1 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Miplyffa | $ 25 | 84.8% |
| Olpruva | $ 0 | 1% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Zevra Therapeutics Inc
Zevra Therapeutics Inc is a biotherapeutics company that focuses on the research, development, and commercialization of innovative therapies to treat various diseases. The company is headquartered in a state-of-the-art facility equipped with cutting-edge laboratories and research infrastructure.
Zevra Therapeutics specializes in the development of biologic drugs, which are drugs derived from living organisms or their components. These drugs have the potential to offer targeted, highly effective treatments for diseases that are otherwise difficult to manage. The company's primary focus is on the development of therapeutics for cancer, autoimmune disorders, and rare genetic diseases.
The research and development activities at Zevra Therapeutics are driven by a team of highly skilled scientists, researchers, and clinicians. They work collaboratively to identify potential drug targets, design novel therapies, and conduct preclinical and clinical trials.
One of the key areas of expertise for Zevra Therapeutics is in the field of immuno-oncology. The company is at the forefront of developing and commercializing immunotherapies that harness the power of the immune system to specifically target and destroy cancer cells. These therapies include monoclonal antibodies, cell-based therapies, and immune modulators.
In addition to immuno-oncology, Zevra Therapeutics is also actively working on the development of therapies for autoimmune disorders. These disorders arise when the immune system mistakenly attacks healthy cells and tissues in the body. The company's goal is to develop innovative therapies that can modulate the immune system and restore its normal function, thereby treating and managing autoimmune diseases effectively.
Furthermore, Zevra Therapeutics is involved in developing therapies for rare genetic diseases. These diseases are caused by genetic mutations and often have limited treatment options available. The company's approach involves the use of gene therapies, which aim to correct the underlying genetic defects and provide long-term relief to patients suffering from these conditions.
To support its research and development efforts, Zevra Therapeutics has established strategic partnerships and collaborations with academic institutions, research organizations, and biotechnology companies. These partnerships not only enhance the company's scientific capabilities but also provide access to valuable resources, technology platforms, and expertise.
In terms of commercialization, Zevra Therapeutics has a dedicated team responsible for securing regulatory approvals and launching its therapies in the market. The team works closely with regulatory authorities to ensure compliance with all necessary regulations and guidelines. The company also works diligently on securing intellectual property rights for its innovative therapies.
Overall, Zevra Therapeutics Inc is a leading biotherapeutics company that is actively engaged in the development and commercialization of innovative therapies for cancer, autoimmune disorders, and rare genetic diseases. With a strong focus on research and collaboration, the company aims to bring breakthrough treatments to patients in need, ultimately improving their quality of life.
Zevra Therapeutics specializes in the development of biologic drugs, which are drugs derived from living organisms or their components. These drugs have the potential to offer targeted, highly effective treatments for diseases that are otherwise difficult to manage. The company's primary focus is on the development of therapeutics for cancer, autoimmune disorders, and rare genetic diseases.
The research and development activities at Zevra Therapeutics are driven by a team of highly skilled scientists, researchers, and clinicians. They work collaboratively to identify potential drug targets, design novel therapies, and conduct preclinical and clinical trials.
One of the key areas of expertise for Zevra Therapeutics is in the field of immuno-oncology. The company is at the forefront of developing and commercializing immunotherapies that harness the power of the immune system to specifically target and destroy cancer cells. These therapies include monoclonal antibodies, cell-based therapies, and immune modulators.
In addition to immuno-oncology, Zevra Therapeutics is also actively working on the development of therapies for autoimmune disorders. These disorders arise when the immune system mistakenly attacks healthy cells and tissues in the body. The company's goal is to develop innovative therapies that can modulate the immune system and restore its normal function, thereby treating and managing autoimmune diseases effectively.
Furthermore, Zevra Therapeutics is involved in developing therapies for rare genetic diseases. These diseases are caused by genetic mutations and often have limited treatment options available. The company's approach involves the use of gene therapies, which aim to correct the underlying genetic defects and provide long-term relief to patients suffering from these conditions.
To support its research and development efforts, Zevra Therapeutics has established strategic partnerships and collaborations with academic institutions, research organizations, and biotechnology companies. These partnerships not only enhance the company's scientific capabilities but also provide access to valuable resources, technology platforms, and expertise.
In terms of commercialization, Zevra Therapeutics has a dedicated team responsible for securing regulatory approvals and launching its therapies in the market. The team works closely with regulatory authorities to ensure compliance with all necessary regulations and guidelines. The company also works diligently on securing intellectual property rights for its innovative therapies.
Overall, Zevra Therapeutics Inc is a leading biotherapeutics company that is actively engaged in the development and commercialization of innovative therapies for cancer, autoimmune disorders, and rare genetic diseases. With a strong focus on research and collaboration, the company aims to bring breakthrough treatments to patients in need, ultimately improving their quality of life.
Zevra Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapeutic solutions for patients with rare diseases and underserved medical conditions. Below is an extensive breakdown of the segments, products, and services that Zevra Therapeutics offers.
Segments
Zevra Therapeutics primarily operates within the pharmaceutical and biotechnology sector, with a focus on the following segments:
1. Rare Diseases: The company is dedicated to addressing diseases that have limited treatment options and affect small patient populations. This segment involves the development of therapies aimed at providing relief and improving the quality of life for those suffering from these conditions.
2. Central Nervous System Disorders: Zevra invests significant resources into the research and development of treatments for neurological and psychological conditions that can severely impact daily living.
3. Specialty Pharmaceuticals: The company also engages in the development of specialty medications that require unique knowledge regarding their application and management, often in collaboration with healthcare providers to ensure optimal patient outcomes.
Products
Zevra Therapeutics develops a range of innovative products, often in various stages of clinical trials, to address the needs of patients with rare and complex diseases. Some prominent product areas include:
1. Therapeutics for Rare Diseases:
- These products specifically target conditions such as genetic disorders and metabolic conditions. The company aims to provide unique therapeutic options that are not available in the mainstream market.
- Examples may include enzyme replacement therapies or gene therapies designed to address specific genetic mutations.
2. Neurology-focused Products:
- The companys portfolio includes treatments for conditions such as neuropathic pain, multiple sclerosis, and other disorders that affect the central nervous system.
- Products in this area often address symptoms that are debilitating and improve both functional and emotional aspects of the patient’s life.
3. Dual Mechanism Therapies:
- These are innovative formulations that target multiple pathways or symptoms in a single treatment, aimed at providing comprehensive care for complex conditions.
Services
In addition to its product offerings, Zevra Therapeutics provides a range of services that support patients, healthcare providers, and the overall healthcare ecosystem, such as:
1. Patient Support Programs:
- Zevra offers resources that help patients navigate their treatment options. These programs may include educational resources, medication management support, and connectivity with support networks.
2. Clinical Trials and Research Collaboration:
- The company actively engages in clinical research to better understand the gaps in treatment for rare diseases. By partnering with academic institutions and healthcare organizations, Zevra works to push the boundaries of current medical knowledge and therapeutic options.
3. Regulatory and Compliance Consulting:
- With the complexities of bringing a drug to market, Zevra provides services that help navigate FDA regulations and other international compliance requirements, ensuring that their products can reach patients effectively and efficiently.
Conclusion
Zevra Therapeutics Inc. is committed to advancing the field of rare disease treatment through innovative therapeutics, dedicated research, and comprehensive patient support services. The companys focus on underserved medical conditions positions it uniquely within the pharmaceutical landscape, aiming to improve the lives of individuals facing challenging health conditions. Through its various segments, products, and services, Zevra Therapeutics strives to meet the evolving needs of patients and caregivers alike.
Segments
Zevra Therapeutics primarily operates within the pharmaceutical and biotechnology sector, with a focus on the following segments:
1. Rare Diseases: The company is dedicated to addressing diseases that have limited treatment options and affect small patient populations. This segment involves the development of therapies aimed at providing relief and improving the quality of life for those suffering from these conditions.
2. Central Nervous System Disorders: Zevra invests significant resources into the research and development of treatments for neurological and psychological conditions that can severely impact daily living.
3. Specialty Pharmaceuticals: The company also engages in the development of specialty medications that require unique knowledge regarding their application and management, often in collaboration with healthcare providers to ensure optimal patient outcomes.
Products
Zevra Therapeutics develops a range of innovative products, often in various stages of clinical trials, to address the needs of patients with rare and complex diseases. Some prominent product areas include:
1. Therapeutics for Rare Diseases:
- These products specifically target conditions such as genetic disorders and metabolic conditions. The company aims to provide unique therapeutic options that are not available in the mainstream market.
- Examples may include enzyme replacement therapies or gene therapies designed to address specific genetic mutations.
2. Neurology-focused Products:
- The companys portfolio includes treatments for conditions such as neuropathic pain, multiple sclerosis, and other disorders that affect the central nervous system.
- Products in this area often address symptoms that are debilitating and improve both functional and emotional aspects of the patient’s life.
3. Dual Mechanism Therapies:
- These are innovative formulations that target multiple pathways or symptoms in a single treatment, aimed at providing comprehensive care for complex conditions.
Services
In addition to its product offerings, Zevra Therapeutics provides a range of services that support patients, healthcare providers, and the overall healthcare ecosystem, such as:
1. Patient Support Programs:
- Zevra offers resources that help patients navigate their treatment options. These programs may include educational resources, medication management support, and connectivity with support networks.
2. Clinical Trials and Research Collaboration:
- The company actively engages in clinical research to better understand the gaps in treatment for rare diseases. By partnering with academic institutions and healthcare organizations, Zevra works to push the boundaries of current medical knowledge and therapeutic options.
3. Regulatory and Compliance Consulting:
- With the complexities of bringing a drug to market, Zevra provides services that help navigate FDA regulations and other international compliance requirements, ensuring that their products can reach patients effectively and efficiently.
Conclusion
Zevra Therapeutics Inc. is committed to advancing the field of rare disease treatment through innovative therapeutics, dedicated research, and comprehensive patient support services. The companys focus on underserved medical conditions positions it uniquely within the pharmaceutical landscape, aiming to improve the lives of individuals facing challenging health conditions. Through its various segments, products, and services, Zevra Therapeutics strives to meet the evolving needs of patients and caregivers alike.